DUALITYBIO-B has been included in the Hang Seng Composite Index constituents
DUALITYBIO-B announced that starting from September 8, 2025, it will be included in the Hang Seng Composite Index constituents and the list of eligible stocks under the Hong Kong Stock Connect. This move indicates the capital market's recognition of the company and is expected to expand the investor base and increase the trading liquidity of its shares
According to the announcement from DUALITYBIO-B (09606), starting from September 8, 2025, the company's shares will (i) be included in the Hang Seng Composite Index constituents by Hang Seng Indexes Company Limited and (ii) be added to the list of eligible stocks under the Stock Connect program.
The inclusion of shares in the Hang Seng Composite Index and the eligible securities for Stock Connect represents a high recognition of the company's performance and value by the capital market, allowing qualified investors in mainland China to directly invest in shares listed on Hong Kong Exchanges and Clearing Limited through the Shanghai Stock Exchange. This inclusion is expected to further expand the company's investor base and is likely to increase the trading liquidity of the shares
